Japan Hearing Loss Disease Treatment Market Size & Outlook
Japan hearing loss disease treatment market, 2018-2030 (US$M)
Related Markets
Japan hearing loss disease treatment market highlights
- The Japan hearing loss disease treatment market generated a revenue of USD 708.3 million in 2023 and is expected to reach USD 1,134.0 million by 2030.
- The Japan market is expected to grow at a CAGR of 7% from 2024 to 2030.
- In terms of segment, devices was the largest revenue generating product in 2023.
- Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Hearing loss disease treatment market data book summary
| Market revenue in 2023 | USD 708.3 million |
| Market revenue in 2030 | USD 1,134.0 million |
| Growth rate | 7% (CAGR from 2023 to 2030) |
| Largest segment | Devices |
| Fastest growing segment | Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Devices, Drugs |
| Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 5.2% of the global hearing loss disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China hearing loss disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,211.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hearing Loss Disease Treatment Market Scope
Hearing Loss Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan hearing loss disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 89.98% in 2023. Horizon Databook has segmented the Japan hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
The geriatric population in Japan is increasing rapidly, wherein both life expectancy and per capita income of population aged 80 and above are high. Problems associated with hearing are majorly related to aging. To deal with this situations, various research and development activities are being conducted.
In May 2021, a group of researchers at Kobe University found out the relation between inner-cells and acquired hearing loss. This discovery can lead to superior treatment and prevention of hearing loss.
Furthermore, in July 2022, the collaboration of Mogrify Limited and Astellas Pharma, Inc., a leader in regenerative medicine, announced strategic plan to develop and commercialize in vivo regenerative medicine with an aim to address sensorineural hearing loss.
Reasons to subscribe to Japan hearing loss disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan hearing loss disease treatment market databook
-
Our clientele includes a mix of hearing loss disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into Japan hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan hearing loss disease treatment market report size, by product, 2018-2030 (US$M)
Japan Hearing Loss Disease Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
